<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00142922</url>
  </required_header>
  <id_info>
    <org_study_id>DK 60115 (completed)</org_study_id>
    <secondary_id>DK 60115</secondary_id>
    <secondary_id>CHS00-34</secondary_id>
    <nct_id>NCT00142922</nct_id>
  </id_info>
  <brief_title>Breaking Down Barriers to Diabetes Self-Care</brief_title>
  <official_title>Breaking Down Barriers to Diabetes Self-Care</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Performance of self-care recommendations is key to the successful treatment of diabetes.&#xD;
      However, many patients have difficulty adhering to diabetes self-care recommendations. Recent&#xD;
      results from our own studies and others have identified specific barriers to diabetes&#xD;
      self-care. To evaluate the efficacy of a diabetes educator-led group intervention, the&#xD;
      Breaking Down Barriers Program, that addresses barriers and therefore leads to improved&#xD;
      adherence to diabetes self-care recommendations, we will randomize 222 (111 type 1 and 111&#xD;
      type 2) diabetes patients to one of three conditions: 1) the Breaking Down Barriers Program,&#xD;
      2) a cholesterol attention control condition, or 3) a 'usual care' control condition. We&#xD;
      hypothesize that those assigned to the Breaking Down Barriers group will improve self-care&#xD;
      behaviors and glycemic control more than those in the two control groups. We will follow&#xD;
      study subjects for one year to determine whether their self-care behaviors and glycemic&#xD;
      control improved and if the improvement was maintained over time.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2002</start_date>
  <completion_date>October 2007</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Self-Care Behaviors</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Glycemic control (HbA1c)</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>fitness</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diabetes Related emaitonal distress</measure>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment>222</enrollment>
  <condition>Type 1 Diabetes</condition>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Attended Breaking Down Barriers program</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Attention control group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Indivdual attention control group</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Breaking Down Barriers</intervention_name>
    <description>completed</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        For Patients With Type 1 Diabetes&#xD;
&#xD;
          -  Aged 18-65&#xD;
&#xD;
          -  Presence of type 1 diabetes mellitus.&#xD;
&#xD;
          -  2-25 year duration.&#xD;
&#xD;
        For Patients With Type 2 Diabetes&#xD;
&#xD;
          -  Aged 25-65 years&#xD;
&#xD;
          -  presence of type 2 diabetes mellitus.&#xD;
&#xD;
          -  2 years since initial diagnosis.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Renal disease, microalbumin &gt;300 ug/mg)&#xD;
&#xD;
          -  Severe peripheral diabetic neuropathy and/or severe peripheral vascular disease&#xD;
&#xD;
          -  Symptomatic severe autonomic neuropathy who may be at risk when increasing activity&#xD;
             levels.&#xD;
&#xD;
          -  Women who are currently pregnant&#xD;
&#xD;
          -  proliferative diabetic retinopathy based on dilated eye examination within one year of&#xD;
             study entry. Patients whose eye disease is successfully treated will be included.&#xD;
&#xD;
          -  HbA1c levels less than 7.0% (normal range 4.0 - 6.0%).&#xD;
&#xD;
          -  HbA1c levels greater than 14.0%&#xD;
&#xD;
          -  patients who underwent intensive insulin treatment within one year&#xD;
&#xD;
          -  a history of severe, unstable myocardial infarction, congestive heart failure or other&#xD;
             severe cardiac disease, severe hypertension (systolic more than 160 mmHg or diastolic&#xD;
             90 mmHg) who may be at risk when mildly increasing physical activity&#xD;
&#xD;
          -  a DSMIV diagnosis of eating disorders including anorexia nervosa, bulimia, and severe&#xD;
             weight-related insulin omission.&#xD;
&#xD;
          -  Patients with recent diagnosis (past 6 months) of bipolar disorder, schizophrenia,&#xD;
             mental retardation, organic mental disorder, and alcohol or drug abuse&#xD;
&#xD;
          -  Patients whose diabetes diagnosed cannot be clearly classified as type 1 or type 2.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Katie Weinger, EdD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Joslin Diabetes Center/Harvard Medical School</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Joslin Diabetes Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2010</verification_date>
  <study_first_submitted>August 31, 2005</study_first_submitted>
  <study_first_submitted_qc>August 31, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 2, 2005</study_first_posted>
  <last_update_submitted>March 1, 2010</last_update_submitted>
  <last_update_submitted_qc>March 1, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 2, 2010</last_update_posted>
  <keyword>Adherence</keyword>
  <keyword>self-care</keyword>
  <keyword>Behavioral intervention</keyword>
  <keyword>Diabetes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

